| Ardent Home Health Care Agency Corp | |
| 3311 S Rainbow Blvd Ste 107, Las Vegas, Nevada 89146 | |
| (702) 476-5258 | |
| Name | Ardent Home Health Care Agency Corp |
|---|---|
| Location | 3311 S Rainbow Blvd Ste 107, Las Vegas, Nevada |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Medical Social Services Home Health Aide |
| Medicare ID | 297226 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 89012, 89014, 89030, 89031, 89032, 89052, 89074, 89081, 89084, 89101, 89102, 89103, 89104, 89106, 89107, 89108, 89110, 89115, 89117, 89120, 89121, 89122, 89123, 89129, 89130, 89134, 89135, 89141, 89142, 89145, 89146, 89147, 89148, 89149, 89179 |
| NPI Number | 1972952521 |
| Organization Name | ARDENT HOME HEALTH CARE |
| Doing Business As | ARDENT HOME HEALTH CARE AGENCY CORP |
| Address | 3311 S Rainbow Blvd, Ste 104, Las Vegas, NV 89146 |
| Phone Number | 702-476-5258 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis' breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva's Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.
Brussels bureaucrats faced ridicule for banning drink manufacturers from claiming that water can prevent dehydration. EU officials concluded that, following a three-year investigation, there was no evidence to prove the previously undisputed fact. And now manufacturers of bottled water are forbidden by law from making the claim and will face a two-year jail sentence if they defy the edict, which comes into force in the UK next month.
Jon D. Duke, M.D. and Jeffrey Klann, M.Eng., medical informatics fellows at the Regenstrief Institute and Indiana University School of Medicine, have been recognized by the American Medical Informatics Association for their development and testing of two new physician support computer tools. Their
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that AVEO has regained worldwide rights from Merck (through its subsidiary, Schering Corporation) to develop and commercialize AV-299 (also known as SCH 900105), its anti-hepatocyte growth factor (HGF) antibody candidate.
Mares that are fed a diet that includes or is solely comprised of concentrates during gestation are significantly more likely to produce foals that develop permanent osteochondrosis lesions compared with mares who are fed a diet of roughage alone, report researchers.
› Verified 7 days ago
| Quality Rating: |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis' breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva's Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.
Brussels bureaucrats faced ridicule for banning drink manufacturers from claiming that water can prevent dehydration. EU officials concluded that, following a three-year investigation, there was no evidence to prove the previously undisputed fact. And now manufacturers of bottled water are forbidden by law from making the claim and will face a two-year jail sentence if they defy the edict, which comes into force in the UK next month.
Jon D. Duke, M.D. and Jeffrey Klann, M.Eng., medical informatics fellows at the Regenstrief Institute and Indiana University School of Medicine, have been recognized by the American Medical Informatics Association for their development and testing of two new physician support computer tools. Their
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that AVEO has regained worldwide rights from Merck (through its subsidiary, Schering Corporation) to develop and commercialize AV-299 (also known as SCH 900105), its anti-hepatocyte growth factor (HGF) antibody candidate.
Mares that are fed a diet that includes or is solely comprised of concentrates during gestation are significantly more likely to produce foals that develop permanent osteochondrosis lesions compared with mares who are fed a diet of roughage alone, report researchers.
› Verified 7 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 82 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 97.3 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 94.6 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 19.5 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 19.6 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 88.5 | 96.4 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis' breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva's Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.
Brussels bureaucrats faced ridicule for banning drink manufacturers from claiming that water can prevent dehydration. EU officials concluded that, following a three-year investigation, there was no evidence to prove the previously undisputed fact. And now manufacturers of bottled water are forbidden by law from making the claim and will face a two-year jail sentence if they defy the edict, which comes into force in the UK next month.
Jon D. Duke, M.D. and Jeffrey Klann, M.Eng., medical informatics fellows at the Regenstrief Institute and Indiana University School of Medicine, have been recognized by the American Medical Informatics Association for their development and testing of two new physician support computer tools. Their
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that AVEO has regained worldwide rights from Merck (through its subsidiary, Schering Corporation) to develop and commercialize AV-299 (also known as SCH 900105), its anti-hepatocyte growth factor (HGF) antibody candidate.
Mares that are fed a diet that includes or is solely comprised of concentrates during gestation are significantly more likely to produce foals that develop permanent osteochondrosis lesions compared with mares who are fed a diet of roughage alone, report researchers.
› Verified 7 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 66.7 | 79.6 |
| How often patients got better at getting in and out of bed | 74 | 81.1 |
| How often patients got better at bathing | 67.4 | 82.3 |
| How often patients’ breathing improved | 51.8 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 73 | 75 |
| How often home health patients had to be admitted to the hospital | 16.8 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 7.7 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 44.6 | 94 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis' breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva's Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.
Brussels bureaucrats faced ridicule for banning drink manufacturers from claiming that water can prevent dehydration. EU officials concluded that, following a three-year investigation, there was no evidence to prove the previously undisputed fact. And now manufacturers of bottled water are forbidden by law from making the claim and will face a two-year jail sentence if they defy the edict, which comes into force in the UK next month.
Jon D. Duke, M.D. and Jeffrey Klann, M.Eng., medical informatics fellows at the Regenstrief Institute and Indiana University School of Medicine, have been recognized by the American Medical Informatics Association for their development and testing of two new physician support computer tools. Their
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that AVEO has regained worldwide rights from Merck (through its subsidiary, Schering Corporation) to develop and commercialize AV-299 (also known as SCH 900105), its anti-hepatocyte growth factor (HGF) antibody candidate.
Mares that are fed a diet that includes or is solely comprised of concentrates during gestation are significantly more likely to produce foals that develop permanent osteochondrosis lesions compared with mares who are fed a diet of roughage alone, report researchers.
› Verified 7 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | Not Available |
| Health team communicated well with them | Not Available |
| Health team discussed medicines, pain, and home safety | Not Available |
| How patients rated overall care from agency | Not Available |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis' breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva's Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.
Brussels bureaucrats faced ridicule for banning drink manufacturers from claiming that water can prevent dehydration. EU officials concluded that, following a three-year investigation, there was no evidence to prove the previously undisputed fact. And now manufacturers of bottled water are forbidden by law from making the claim and will face a two-year jail sentence if they defy the edict, which comes into force in the UK next month.
Jon D. Duke, M.D. and Jeffrey Klann, M.Eng., medical informatics fellows at the Regenstrief Institute and Indiana University School of Medicine, have been recognized by the American Medical Informatics Association for their development and testing of two new physician support computer tools. Their
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that AVEO has regained worldwide rights from Merck (through its subsidiary, Schering Corporation) to develop and commercialize AV-299 (also known as SCH 900105), its anti-hepatocyte growth factor (HGF) antibody candidate.
Mares that are fed a diet that includes or is solely comprised of concentrates during gestation are significantly more likely to produce foals that develop permanent osteochondrosis lesions compared with mares who are fed a diet of roughage alone, report researchers.
› Verified 7 days ago
The patient survey data of Ardent Home Health Care Agency Corp is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 87 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 80 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 82 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 80 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 81 | 78 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis' breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva's Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.
Brussels bureaucrats faced ridicule for banning drink manufacturers from claiming that water can prevent dehydration. EU officials concluded that, following a three-year investigation, there was no evidence to prove the previously undisputed fact. And now manufacturers of bottled water are forbidden by law from making the claim and will face a two-year jail sentence if they defy the edict, which comes into force in the UK next month.
Jon D. Duke, M.D. and Jeffrey Klann, M.Eng., medical informatics fellows at the Regenstrief Institute and Indiana University School of Medicine, have been recognized by the American Medical Informatics Association for their development and testing of two new physician support computer tools. Their
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that AVEO has regained worldwide rights from Merck (through its subsidiary, Schering Corporation) to develop and commercialize AV-299 (also known as SCH 900105), its anti-hepatocyte growth factor (HGF) antibody candidate.
Mares that are fed a diet that includes or is solely comprised of concentrates during gestation are significantly more likely to produce foals that develop permanent osteochondrosis lesions compared with mares who are fed a diet of roughage alone, report researchers.
› Verified 7 days ago
Advisacare Solutions Of Nevada, Inc Location: 1840 E Warm Springs Rd Suite 100, Las Vegas, Nevada 89119 Ratings: Phone: (702) 896-6393 | |
Southwest Medical Associates Home Health Location: 8655 S Eastern Ave, Las Vegas, Nevada 89123 Ratings: Phone: (702) 383-0887 | |
In House Home Health Inc. Location: 3075 East Flamingo Road, Suite #116, Las Vegas, Nevada 89121 Ratings: Phone: (702) 894-9449 | |
Harmony Home Health Location: 820 Rancho Ln #20, Las Vegas, Nevada 89106 Ratings: Phone: (702) 880-7525 | |
Always Better Care Location: 6950 Via Olivero Ave Ste B4, Las Vegas, Nevada 89117 Ratings: Phone: (702) 364-8006 | |
Kindred At Home Location: 9121 West Russell Ste 118, Las Vegas, Nevada 89148 Ratings: Phone: (702) 228-0282 |